1.
Zordan M, Fiorio E, Maffeis V, Mafficini A, Querzoli G, Barioglio B, Biondani P, Brunelli M, Invento A, Pellini F, Luchini C, Scarpa A, Nottegar A. HER2-positive neuroendocrine breast carcinoma: a case study uncovers CCND1, FGF19, and IGF1R amplifications as new molecular drivers. Pathologica [Internet]. 2025 Oct. 17 [cited 2025 Oct. 18];117(4). Available from: https://www.pathologica.it/article/view/981